Published Papers & Misc - YOKOZEKI Hiroo

Division display  221 - 240 of about 241 ／  All the affair displays >>

  1. Yamamoto T, Yokozeki H.. Subcutaneous sarcoidal granuloma underlying porokeratosis in a patient with sarcoid-lymphoma syndrome. Eur J Dermatol.. 2015.02; 25 (1): 84-85.

  2. Kondo T, Namiki T, Coelho SG, Valencia JC, Hearing VJ.. Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4. J Dermatol Sci. . 2015.01; 77 (1): 21-27.

  3. Shibama S, Igawa K, Munetsugu T, Fukuyama K, Nishizawa A, Takayama K, Yokozeki H. A case of sarcoidosis presenting as livedo. Ann Dermatol. . 2014; 26 (6): 773-774.

  4. Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O'Shea JJ, Katz SI.. Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib. J Invest Dermatol. . 2014; 134 (4): 992-1000.

  5. Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI.. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease. J Invest Dermatol.. 2014; 134 (6): 1552-1560.

  6. Oishi K, Hamaguchi Y, Matsushita T, Hasegawa M, Okiyama N, Dernedde J, Weinhart M, Haag R, Tedder TF, Takehara K, Kohsaka H, Fujimoto M.. A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. Arthritis Rheumatol. . 2014; 66 (7): 1864-1871.

  7. Okiyama N, Katz SI.. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes. J Autoimmun. . 2014; 53 1-9.

  8. Takayama N, Nakazono S, Kumagai J, Kawamura T, Suzuki F, Ishii N, Hashimoto T, Namiki T. . Case of subepidermal bullous disease with diffuse esophageal involvement presenting with immunoglobulin G autoantibodies to both the BP180 NC16a and C-terminal domains, and immunoglobulin A autoantibodies to the BP180 NC16a domain. J Dermatol. . 2014; 41 (7): 665-667.

  9. Nakazono S, Takayama N, Nojima K, Kumagai J, Izumi M, Namiki T. . Well-differentiated syringomatous carcinoma with solid carcinoma-like features. J Dermatol. . 2014; 41 (12): 1126-1127.

  10. Inoue T, Yamaoka T, Murota H, Yokomi A, Tanemura A, Igawa K, Tani M, Katayama I. . Effective oral psoralen plus ultraviolet a therapy for digital ulcers with revascularization in systemic sclerosis. Acta Derm Venereol. . 2014; 94 (2): 250-251.

  11. Senda S, Igawa K, Nishioka M, Murota H, Katayama I.. Systemic sclerosis with sarcoidosis: case report and review of the published work. J Dermatol. . 2014; 41 (5): 421-423.

  12. Kato K, Hanafusa T, Igawa K, Tatsumi M, Takahashi Y, Yamanaka T, Katayama I.. A rare case of annular pustular psoriasis associated with pemphigus foliaceus. Ann Dermatol. . 2014; 26 (2): 260-261.

  13. Hashimoto T, Satoh T, Furuya A, Kataoka N, Yokozeki H.. Kimura's disease with prurigo lesions treated with systemic indomethacin. J Eur Acad Dermatol Venereol. . 2014; 28 (9): 1260-1262.

  14. Inazawa M, Satoh T, Yokozeki H.. Hyperkeratotic variant of inflammatory disseminated superficial porokeratosis with lichenoid reaction and extensive amyloid deposition. Int J Dermatol. . 2014; 53 (2): 94-95.

  15. Higuchi T, Satoh T, Yokozeki H.. Using CD40 ligand expression to detect antigen-specific T cells in patients with drug eruptions. Acta Derm Venereol. . 2014; 94 (1): 86-87.

  16. Nakazono S, Nojima K, Kumagai J, Hagiyama H, Yokozeki H, Namiki T.. Amicrobial pustulosis-like rash associated with systemic lupus erythematosus. J Dermatol.. 2014; 41 (4): 359-360.

  17. Yokozeki H.. A nucleic acid-based medication for allergic skin diseases. J Dermatol Sci. . 2014; 75 (2): 75-81.

  18. Ueno M, Aoto T, Mohri Y, Yokozeki H, Nishimura EK.. Coupling of the radiosensitivity of melanocyte stem cells to their dormancy during the hair cycle. Pigment Cell Melanoma Res. . 2014; 27 (4): 540-551.

  19. Igawa K, Kokubu C, Yusa K, Horie K, Yoshimura Y, Yamauchi K, Suemori H, Yokozeki H, Toyoda M, Kiyokawa N, Okita H, Miyagawa Y, Akutsu H, Umezawa A, Katayama I, Takeda J.. Removal of Reprogramming Transgenes Improves the Tissue Reconstitution Potential of Keratinocytes Generated From Human Induced Pluripotent Stem Cells. Stem Cells Transl Med. . 2014; 3 (9): 992-1001.

  20. Nishizawa A, Igawa K, Teraki H, Yokozeki H.. Diffuse disseminated lichenoid-type cutaneous sarcoidosis mimicking erythroderma. Int J Dermatol. . 2014; 53 (8): 369-370.

< PREV - NEXT >

To the head of this page.▲